Cardiac Resynchronization Therapy Devices Market
Dec 13, 2023
Understanding the Growth and the Evolving Market Dynamics of Cardiac Rhythm Management Devices
Globally, cardiovascular diseases (CVDs) stand as the primary cause of mortality, claiming an estimated 17.9 million lives in 2019 alone, which accounted for 32% of all global deaths. Among these fatalities, a staggering 85% were attributed to heart attacks and strokes. Within the spectrum of noncommunicable diseas...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
